key: cord-0019069-3eg9id9p authors: Cawcutt, Kelly A.; Van Schooneveld, Trevor C. title: Caution, not causality: The limitations of risk factor and outcome research on ventilator-associated events date: 2021-05-03 journal: nan DOI: 10.1017/ice.2021.194 sha: 7c5cc3c86f6b48cdc961ea2d6659df76eff92a4f doc_id: 19069 cord_uid: 3eg9id9p nan ventilator-associated complications (IVACs), and 191 PVAPs. Major baseline differences were detected between the VAE and non-VAE groups, specifically in APACHE II, chronic lower respiratory tract infection surgical intervention, and many of the outcomes of interest. The authors evaluated 7 of the 8 outcomes of interest using propensity scoring matching with numerous variables in an attempt to account for these differences. They were unable to analyze duration on a ventilator because the populations could not be well matched. In all other analyses, outcomes were significantly worse in the group with VAE, and this persisted when the authors performed multivariate regression and sensitivity analyses. VAE subtype (VAC, IVAC, or PVAP) analysis demonstrated no difference in LOS, but IVAC and PVAP had increased duration of mechanical ventilation. Risk factors identified for mortality included older age, high APACHE II scores on ICU admission, presence of pneumonia, need for blood transfusion, immunosuppressive medications, presence of central venous catheters, and ≥2 VAE episodes during an ICU stay. Surgical operations and tracheotomy were associated with lower risks of mortality. The clear strengths of this study include the large cohort of patients, standardized surveillance using established CDC methodology, and robust analyses of multiple outcomes. These findings strongly support that VAE development portends multiple worsened outcomes. These findings also support the argument that VAE identification is clinically meaningful and that it may be a useful quality metric. Quality metrics that detect conditions that impact patient outcomes are ideal, but they are most useful when they can be coupled with well-established mitigation strategies. Unfortunately, high-quality evidence regarding optimal prevention strategies for VAE are lacking, and previously used strategies for VAP prevention have not proven useful in VAE prevention. 2, 4 Evidence-based recommendations exist for prevention of VAP, but many are based on moderate or low-quality evidence, resulting in debate regarding overall utility. 1 These interventions can also easily fail if they are ineffectively implemented. VAE prevention is a difficult task because the condition represents a mixture of conditions ranging from pneumonia to volume overload to pulmonary embolism and more; therefore, prevention strategies must be multifaceted. The most effective interventions for VAE prevention and subsequent VAP prevention may be strategies that decrease duration of mechanical ventilation and therefore time at risk for VAE. Trials utilizing spontaneous awakening and breathing trials have demonstrated decreased time on the ventilator and decreased VAE rates. 2,6−8 These strategies, coupled with minimization of sedation, early mobility, use of low tidal ventilation, and conservative fluid and blood product, have all shown some success in decreasing the conditions associated with VAE (eg, pneumonia, atelectasis, acute respiratory distress syndrome (ARDS), pulmonary edema, and more). 1, 7, 8 We suggest focusing on PVAPs rather than the entire VAE umbrella. This is a cautionary statistical tale of weighting association as causality. First, VAE, with VAC, is the gatekeeper to reach PVAP, comprising the minority of patients within the group (only 10% of the VAEs met PVAP criteria). If outcomes are worse for all VAEs, the argument to prevent PVAP alone is weakened, and preventing VAEs prevents PVAPs. We also appropriately suggest caution regarding the risk of blood transfusions and central venous catheter placement in the ICU for VAE. This study does not have the strength in design or results to determine whether transfusion or CVCs have a causal role, nor can the results be extrapolated to state avoidance of transfusion or CVC placement could prevent VAEs. Because severity of illness was only assessed on ICU admission, these may simply be markers of level of illness. Additionally, blood transfusions have been associated with negative immune modulation, and numerous studies have found more aggressive transfusion strategies to be associated with negative outcomes, further confounding the situation. 9 Worse patient outcomes are increasingly attributed to VAEs, suggesting that surveillance and metric reporting carry value. However, optimal preventative strategies remain unclear. The focus is no longer simply on preventing pneumonia but requires a multifaceted, holistic approach to hasten liberation from mechanical ventilation. Further prospective studies on specific strategies to mitigate the impact of VAE on patient-centered outcomes are needed. Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update Barriers to the adoption of ventilator-associated events surveillance and prevention Does ventilator-associated event surveillance detect ventilator-associated pneumonia in intensive care units? A systematic review and meta-analysis Ventilator bundle compliance and risk of ventilator-associated events Clinical outcomes and risk factors for mortality from ventilator-associated events: a registry-based cohort study among 30,830 intensive care unit patients 776: Compliance with spontaneous breathing trial protocol associated with lower VAE rates Potential strategies to prevent ventilator-associated events The preventability of ventilatorassociated events. The CDC prevention epicenters wake up and breathe collaborative Healthcare-associated infection after red blood-cell transfusion: a systematic review and meta-analysis Acknowledgments.Financial support. No financial support was provided relevant to this article. All authors report no conflicts of interest relevant to this article.